This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Aetna Cited By KLAS Research As ‘Transformational Partner’ For Providers

In its first report on Accountable Care Payers issued today, KLAS, an independent researcher of technology and solutions for the health care provider market, cited Aetna (NYSE: AET) as having the most transformational relationships as compared to other payers based on interviews with providers that have implemented accountable care models. Aetna is described as “forward-thinking” and a “flexible partner that adjusts to meet provider goals and needs.” In the report “ Accountable Care Payers: Partners in a Changing Paradigm,” one provider said, “Aetna was good to work with and very flexible as we started. ...They have all the tools and bells and whistles that organizations need to be an ACO.”

“As the industry moves toward payment models based on quality and accountability, forward-thinking provider organizations are looking to payers for the resources and expertise they need to take on more risk,” said Mark Allphin, author of the report and research director at KLAS. “Commercial payers offer a range of innovative approaches for successfully making the transition to accountable care, from simple shared savings agreements all of the way to private-label health plans.”

“Through our Accountable Care Solutions business, we offer the technology, programs and health plan infrastructure that enable ACOs to deliver better quality, more efficient patient care and get rewarded for better results,” said Charles D. Kennedy, chief executive officer, Accountable Care Solutions from Aetna. “Rather than paying for itemized services, we have deployed innovative financial models to share risk and reward with providers and jointly created new health plan products in local markets that offer more options for employers and consumers. Further, we work with providers in a ‘payer-neutral’ manner to share our extensive knowledge and integrated suite of technology and care management solutions from Healthagen. Our capabilities enable providers to deliver accountable care to all their patients, not just Aetna members.”

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,643.01 -11.76 -0.07%
S&P 500 1,988.87 +1.21 0.06%
NASDAQ 4,828.3250 +15.6170 0.32%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs